1. Home
  2. MI vs NXTS Comparison

MI vs NXTS Comparison

Compare MI & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NFT Limited

MI

NFT Limited

HOLD

Current Price

$15.86

Market Cap

3.3M

ML Signal

HOLD

NXTS

Nexentis Technologies Inc. Common Stock

N/A

Current Price

$6.33

Market Cap

3.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MI
NXTS
Founded
2009
2009
Country
Hong Kong
Israel
Employees
N/A
9
Industry
Catalog/Specialty Distribution
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.3M
3.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MI
NXTS
Price
$15.86
$6.33
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
76.5K
39.0K
Earning Date
05-07-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.55
52 Week High
$19.84
$6.25

Technical Indicators

Market Signals
Indicator
MI
NXTS
Relative Strength Index (RSI) 71.72 65.71
Support Level $2.44 $3.97
Resistance Level $19.84 $6.23
Average True Range (ATR) 1.32 0.71
MACD 0.86 -0.00
Stochastic Oscillator 78.69 65.20

Price Performance

Historical Comparison
MI
NXTS

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

About NXTS Nexentis Technologies Inc. Common Stock

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.

Share on Social Networks: